• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cardiac Toxicity in Patients Treated With Immune Checkpoint Inhibitors: It Is Now Time for Cardio-Immuno-Oncology.

作者信息

Tocchetti Carlo G, Galdiero Maria Rosaria, Varricchi Gilda

机构信息

Department of Translational Medical Sciences, Center for Basic and Clinical Immunology Research (CISI), WAO Center of Excellence, Federico II University, Naples, Italy.

Department of Translational Medical Sciences, Center for Basic and Clinical Immunology Research (CISI), WAO Center of Excellence, Federico II University, Naples, Italy.

出版信息

J Am Coll Cardiol. 2018 Apr 24;71(16):1765-1767. doi: 10.1016/j.jacc.2018.02.038. Epub 2018 Mar 19.

DOI:10.1016/j.jacc.2018.02.038
PMID:29567211
Abstract
摘要

相似文献

1
Cardiac Toxicity in Patients Treated With Immune Checkpoint Inhibitors: It Is Now Time for Cardio-Immuno-Oncology.接受免疫检查点抑制剂治疗患者的心脏毒性：现在是心脏免疫肿瘤学的时代了。
J Am Coll Cardiol. 2018 Apr 24;71(16):1765-1767. doi: 10.1016/j.jacc.2018.02.038. Epub 2018 Mar 19.
2
Cardiac Toxicity of Immune Checkpoint Inhibitors: Cardio-Oncology Meets Immunology.免疫检查点抑制剂的心脏毒性：心脏肿瘤学与免疫学的交汇
Circulation. 2017 Nov 21;136(21):1989-1992. doi: 10.1161/CIRCULATIONAHA.117.029626.
3
Immune Checkpoint Inhibitor Cardiotoxicity: Understanding Basic Mechanisms and Clinical Characteristics and Finding a Cure.免疫检查点抑制剂心脏毒性：了解基本机制和临床特征并寻找治疗方法。
Annu Rev Pharmacol Toxicol. 2021 Jan 6;61:113-134. doi: 10.1146/annurev-pharmtox-010919-023451. Epub 2020 Aug 10.
4
Cardiotoxicity from immune checkpoint inhibitors.免疫检查点抑制剂引起的心脏毒性。
Int J Cardiol Heart Vasc. 2019 Sep 7;25:100420. doi: 10.1016/j.ijcha.2019.100420. eCollection 2019 Dec.
5
Cardiac Toxicity Associated with Immune Checkpoint Inhibitors: Case Series and Review of the Literature.免疫检查点抑制剂相关的心脏毒性：病例系列及文献综述
Case Rep Oncol. 2019 Mar 21;12(1):260-276. doi: 10.1159/000498985. eCollection 2019 Jan-Apr.
6
Diagnostic Value of the International Society of Cardio-Oncology Definition for Suspected Immune Checkpoint Inhibitor-Associated Myocarditis.国际心脏肿瘤学会对疑似免疫检查点抑制剂相关心肌炎的定义的诊断价值
J Am Heart Assoc. 2023 Apr 18;12(8):e029211. doi: 10.1161/JAHA.122.029211. Epub 2023 Apr 12.
7
Heart failure in cancer: role of checkpoint inhibitors.癌症中的心力衰竭：检查点抑制剂的作用
J Thorac Dis. 2018 Dec;10(Suppl 35):S4323-S4334. doi: 10.21037/jtd.2018.10.07.
8
Cardiac Immune-Related Adverse Events in Immune Checkpoint Inhibition Therapy.免疫检查点抑制疗法中的心脏免疫相关不良事件。
Cardiol Rev. 2019 Mar/Apr;27(2):97-107. doi: 10.1097/CRD.0000000000000217.
9
Immune Checkpoint Inhibitors and Cardiac Toxicity: An Emerging Issue.免疫检查点抑制剂与心脏毒性：一个新出现的问题。
Curr Med Chem. 2018;25(11):1327-1339. doi: 10.2174/0929867324666170407125017.
10
Myocardial Strain Is Not in Vain: Predicting Cardiovascular Risk in Checkpoint Inhibitor Myocarditis.心肌应变并非徒劳：预测检查点抑制剂性心肌炎的心血管风险
JACC Cardiovasc Imaging. 2022 Nov;15(11):1897-1899. doi: 10.1016/j.jcmg.2022.08.008. Epub 2022 Oct 19.

引用本文的文献

1
TSLP: contrasting roles in cancer.胸腺基质淋巴细胞生成素（TSLP）：在癌症中的相反作用
Front Immunol. 2025 Aug 12;16:1627235. doi: 10.3389/fimmu.2025.1627235. eCollection 2025.
2
Risk factors of immune checkpoint inhibitor-related cardiotoxicity: a scoping review.免疫检查点抑制剂相关心脏毒性的危险因素：一项范围综述
Oncologist. 2025 Jul 4;30(7). doi: 10.1093/oncolo/oyaf187.
3
Cardiovascular adverse effects of immunotherapy in cancer: insights and implications.癌症免疫治疗的心血管不良反应：见解与影响
Front Oncol. 2025 Jun 18;15:1601808. doi: 10.3389/fonc.2025.1601808. eCollection 2025.
4
Immune Checkpoint Inhibitors and Cardiovascular Adverse Events.免疫检查点抑制剂与心血管不良事件
ESC Heart Fail. 2025 Apr 10. doi: 10.1002/ehf2.15281.
5
Immuno-related cardio-vascular adverse events associated with immuno-oncological treatments: an under-estimated threat for cancer patients.与免疫肿瘤治疗相关的免疫相关性心血管不良事件：对癌症患者而言是一种被低估的威胁。
Basic Res Cardiol. 2025 Feb;120(1):153-169. doi: 10.1007/s00395-024-01077-7. Epub 2024 Sep 3.
6
Immune Checkpoint Inhibitors and Their Cardiovascular Adverse Effects.免疫检查点抑制剂及其心血管不良反应。
Oncol Rev. 2023 Nov 17;17:11456. doi: 10.3389/or.2023.11456. eCollection 2023.
7
Cytokine dysregulation despite immunoglobulin replacement therapy in common variable immunodeficiency (CVID).尽管进行了免疫球蛋白替代治疗，常见变异性免疫缺陷（CVID）仍存在细胞因子失调。
Front Immunol. 2023 Sep 28;14:1257398. doi: 10.3389/fimmu.2023.1257398. eCollection 2023.
8
Advances in immune checkpoint inhibitors induced-cardiotoxicity.免疫检查点抑制剂诱导的心脏毒性的研究进展。
Front Immunol. 2023 Feb 23;14:1130438. doi: 10.3389/fimmu.2023.1130438. eCollection 2023.
9
Echocardiography-Assessed Changes of Left and Right Ventricular Cardiac Function May Correlate with Progression of Advanced Lung Cancer-A Generating Hypothesis Study.超声心动图评估的左、右心室心功能变化可能与晚期肺癌进展相关——一项生成假设研究
Cancers (Basel). 2022 Sep 29;14(19):4770. doi: 10.3390/cancers14194770.
10
Cardiotoxicity induced by immune checkpoint inhibitor: The complete insight into mechanisms, monitoring, diagnosis, and treatment.免疫检查点抑制剂诱导的心脏毒性：对机制、监测、诊断和治疗的全面洞察。
Front Cardiovasc Med. 2022 Sep 20;9:997660. doi: 10.3389/fcvm.2022.997660. eCollection 2022.